Fung, James <br/><br/>
Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.  [electronic resource] 

 -  Gastroenterology  Oct 2011 
 - 1212-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1528-0012 
<br/><br/><label>Standard No.: </label>10.1053/j.gastro.2011.06.083  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiviral Agents--adverse effects<br/>Biomarkers--blood<br/>Carcinoma, Hepatocellular--surgery<br/>Chi-Square Distribution<br/>DNA, Viral--blood<br/>Female<br/>Guanine--adverse effects<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B virus--genetics<br/>Hepatitis B, Chronic--complications<br/>Hong Kong<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kaplan-Meier Estimate<br/>Liver Cirrhosis--surgery<br/>Liver Neoplasms--surgery<br/>Liver Transplantation<br/>Magnetic Resonance Imaging<br/>Male<br/>Middle Aged<br/>Postoperative Care<br/>Time Factors<br/>Tomography, X-Ray Computed<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult